DekaBank Deutsche Girozentrale’s Vir Biotechnology VIR Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-43,100	Closed	-$1.08M	–	1529
2023 Q2	$1.08M	Hold	43,100	–	–	﹤0.01%	861
2023 Q1	$991K	Hold	43,100	–	–	﹤0.01%	869
2022 Q4	$1.08M	Hold	43,100	–	–	﹤0.01%	855
2022 Q3	$832K	Hold	43,100	–	–	﹤0.01%	918
2022 Q2	$1.12M	Hold	43,100	–	–	﹤0.01%	853
2022 Q1	$1.12M	Buy	43,100 +3,900	+10%	+$116K	﹤0.01%	895
2021 Q4	$1.53M	Buy	39,200 +1,100	+3%	+$43.1K	﹤0.01%	835
2021 Q3	$1.64M	Hold	38,100	–	–	﹤0.01%	769
2021 Q2	$1.77M	Hold	38,100	–	–	0.01%	752
2021 Q1	$1.82M	Hold	38,100	–	–	0.01%	724
2020 Q4	$1.09M	Buy	+38,100	New	+$1.24M	﹤0.01%	847

Other funds holding VIR

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DekaBank Deutsche Girozentrale's VIR Position: Q3 2023 in Review

DekaBank Deutsche Girozentrale sold out of Vir Biotechnology (VIR) in Q3 2023, closing a stake of 43,100 shares — an estimated $1.08M sold.

DekaBank Deutsche Girozentrale first reported a position in VIR in Q4 2020 and held it in 11 quarters. The position peaked at $1.82M in Q1 2021. 214 funds tracked by Wall St. Rank hold VIR as of Q3 2023.

DekaBank Deutsche Girozentrale reported no remaining Vir Biotechnology position as of Q3 2023 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 43,100 Vir Biotechnology shares in Q3 2023, an estimated $1.08M.
DekaBank Deutsche Girozentrale first reported a position in Vir Biotechnology in Q4 2020 and held it in 11 quarters.
DekaBank Deutsche Girozentrale's Vir Biotechnology position peaked at $1.82M in Q1 2021.
214 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2023, filed 13 Nov 2023.